Maintenance of Subcutaneous Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy Patients With Iatrogenic Left Bundle-Branch Block After Septal Myectomy.
作者信息
Narayanan Chockalingam A, Bokhari Nadia, Rowin Ethan J, Maron Martin S, Maron Barry J, Link Mark S, Madias Christopher
机构信息
Tufts Medical Center Boston MA USA.
Lahey Hospital and Medical Center Burlington MA USA.
出版信息
J Am Heart Assoc. 2024 Apr 16;13(8):e033728. doi: 10.1161/JAHA.123.033728. Epub 2024 Apr 2.
Abstract
摘要
相似文献
1
Maintenance of Subcutaneous Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy Patients With Iatrogenic Left Bundle-Branch Block After Septal Myectomy.
J Am Heart Assoc. 2024 Apr 16;13(8):e033728. doi: 10.1161/JAHA.123.033728. Epub 2024 Apr 2.
2
Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.
J Am Coll Cardiol. 2019 Aug 6;74(5):645-655. doi: 10.1016/j.jacc.2019.05.053.
3
Combined use of subcutaneous implantable defibrillator with endovenous left bundle branch pacing in a child with hypertrophic cardiomyopathy.
Rev Esp Cardiol (Engl Ed). 2021 Mar;74(3):265-267. doi: 10.1016/j.rec.2020.06.021. Epub 2020 Aug 13.
4
Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
J Am Heart Assoc. 2016 Feb 12;5(2):e002488. doi: 10.1161/JAHA.115.002488.
5
Ventricular Fibrillation Refractory to Cutaneous Electrical Defibrillation in a Morbidly Obese Pediatric Patient With Hypertrophic Cardiomyopathy: A Case Report.
A A Pract. 2019 Sep 15;13(6):201-203. doi: 10.1213/XAA.0000000000001022.
6
Case report: Removal of a subcutaneous implantable cardiac defibrillator in a pediatric patient with hypertrophic cardiomyopathy after a septal myectomy. Insights on current indications of type of ICD in children with hypertrophic cardiomyopathy and left ventricular tract obstruction.
Front Pediatr. 2022 Sep 14;10:932390. doi: 10.3389/fped.2022.932390. eCollection 2022.
7
Septal myectomy after failed alcohol ablation: Does previous percutaneous intervention compromise outcomes of myectomy?
J Thorac Cardiovasc Surg. 2015 Jul;150(1):159-67.e1. doi: 10.1016/j.jtcvs.2015.03.044. Epub 2015 Mar 31.
8
Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
J Am Heart Assoc. 2015 Jun 29;4(7):e002013. doi: 10.1161/JAHA.115.002013.
9
PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
Circ Arrhythm Electrophysiol. 2014 Aug;7(4):645-51. doi: 10.1161/CIRCEP.113.001299. Epub 2014 Jun 24.
10
Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy.
Heart Rhythm. 2016 Feb;13(2):457-63. doi: 10.1016/j.hrthm.2015.09.007. Epub 2015 Sep 8.
本文引用的文献
1
Case report: Removal of a subcutaneous implantable cardiac defibrillator in a pediatric patient with hypertrophic cardiomyopathy after a septal myectomy. Insights on current indications of type of ICD in children with hypertrophic cardiomyopathy and left ventricular tract obstruction.
Front Pediatr. 2022 Sep 14;10:932390. doi: 10.3389/fped.2022.932390. eCollection 2022.
2
Evidence That Subcutaneous Implantable Cardioverter-Defibrillators Are Effective and Reliable in Hypertrophic Cardiomyopathy.
JACC Clin Electrophysiol. 2020 Aug;6(8):1019-1021. doi: 10.1016/j.jacep.2020.03.015.
3
Inappropriate shock from delayed T-wave oversensing by a subcutaneous implantable cardioverter-defibrillator after septal myectomy for hypertrophic cardiomyopathy.
HeartRhythm Case Rep. 2018 Jun 15;4(9):408-411. doi: 10.1016/j.hrcr.2018.06.004. eCollection 2018 Sep.
4
Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
J Am Heart Assoc. 2016 Feb 12;5(2):e002488. doi: 10.1161/JAHA.115.002488.
Zotero 插件